Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

US Tariffs

A collection of 18 Posts

UK Government Explores Higher Drug Pricing Threshold to Safeguard Pharma Investment Amid US Tariff Pressures post image

UK Government Explores Higher Drug Pricing Threshold to Safeguard Pharma Investment Amid US Tariff Pressures

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth post image

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth

Putin Orders Increased Indian Pharmaceutical Imports to Address Trade Imbalance post image

Putin Orders Increased Indian Pharmaceutical Imports to Address Trade Imbalance

Trump Administration, Pfizer Ink Deal Linking Drug Pricing, Tariffs, and US Manufacturing post image

Trump Administration, Pfizer Ink Deal Linking Drug Pricing, Tariffs, and US Manufacturing

Trump Administration Announces New Pharma Tariffs; Pfizer Secures Exemption with Domestic Manufacturing and Discounted Drug Agreement post image

Trump Administration Announces New Pharma Tariffs; Pfizer Secures Exemption with Domestic Manufacturing and Discounted Drug Agreement

White House Policy Initiatives Influence Pfizer Drug Pricing and Announce New Direct-to-Consumer Platform post image

White House Policy Initiatives Influence Pfizer Drug Pricing and Announce New Direct-to-Consumer Platform

US Pharma Tariffs Threaten Swiss Economy, Impacting Global Drugmakers post image

US Pharma Tariffs Threaten Swiss Economy, Impacting Global Drugmakers

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives post image

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives

US 100% Pharma Tariffs: Singapore's Industry Navigates Uncertainty Amid Global Supply Chain Concerns post image

US 100% Pharma Tariffs: Singapore's Industry Navigates Uncertainty Amid Global Supply Chain Concerns

AstraZeneca's US Listing Plans Spark Concerns for UK Life Sciences Investment post image

AstraZeneca's US Listing Plans Spark Concerns for UK Life Sciences Investment

Indian Pharmaceutical Sector Eyes Long-Term Growth and Diversification Amidst US Tariff Challenges post image

Indian Pharmaceutical Sector Eyes Long-Term Growth and Diversification Amidst US Tariff Challenges

Indian Pharma Navigates Uncertainty Amid US Tariffs and Price Pressures post image

Indian Pharma Navigates Uncertainty Amid US Tariffs and Price Pressures